| Year |
Citation |
Score |
| 2021 |
Gavett BE, Ashendorf L, O'Bryant SE. When is it appropriate to infer cognitive impairment on the basis of premorbid IQ estimates? A simulation study. Psychological Assessment. PMID 34941355 DOI: 10.1037/pas0001101 |
0.771 |
|
| 2020 |
Petersen ME, Zhang F, Schupf N, Krinsky-McHale SJ, Hall J, Mapstone M, Cheema A, Silverman W, Lott I, Rafii MS, Handen B, Klunk W, Head E, Christian B, Foroud T, et al. Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS) study. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12039. PMID 32626817 DOI: 10.1002/Dad2.12039 |
0.362 |
|
| 2020 |
Petersen M, Zhang F, Krinsky-McHale SJ, Silverman W, Lee JH, Pang D, Hall J, Schupf N, O'Bryant SE. Proteomic profiles of prevalent mild cognitive impairment and Alzheimer's disease among adults with Down syndrome. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12023. PMID 32435687 DOI: 10.1002/Dad2.12023 |
0.356 |
|
| 2019 |
Petersen ME, O'Bryant SE. Blood-based biomarkers for Down syndrome and Alzheimer's disease: A systematic review. Developmental Neurobiology. PMID 31389185 DOI: 10.1002/Dneu.22714 |
0.331 |
|
| 2019 |
Vintimilla R, Hall J, Johnson L, O'Bryant S. The relationship of CRP and cognition in cognitively normal older Mexican Americans: A cross-sectional study of the HABLE cohort. Medicine. 98: e15605. PMID 31083252 DOI: 10.1097/MD.0000000000015605 |
0.307 |
|
| 2019 |
Julovich D, Conger T, O'Bryant S, Hall JR. P1-262: AUTOMATED DIAGNOSTIC TESTING FOR DETECTION OF ALZHEIMER'S DISEASE Alzheimer's & Dementia. 15: P339-P340. DOI: 10.1016/J.Jalz.2019.06.817 |
0.313 |
|
| 2019 |
Vintimilla R, Johnson LA, Hall JR, O'Bryant S. P4-429: PREVALENCE OF RISK FACTORS RELATED TO CARDIOVASCULAR DISEASE AND COGNITION: A COMPARISON BETWEEN THE HABLE AND MHAS COHORTS Alzheimer's & Dementia. 15: P1467-P1467. DOI: 10.1016/J.Jalz.2019.06.4101 |
0.328 |
|
| 2018 |
Babulal GM, Quiroz YT, Albensi BC, Arenaza-Urquijo E, Astell AJ, Babiloni C, Bahar-Fuchs A, Bell J, Bowman GL, Brickman AM, Chételat G, Ciro C, Cohen AD, Dilworth-Anderson P, Dodge HH, et al. Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30555031 DOI: 10.1016/J.Jalz.2018.09.009 |
0.33 |
|
| 2018 |
Gavett BE, Stypulkowski K, Johnson L, Hall J, O'Bryant SE. Factor structure and measurement invariance of a neuropsychological test battery designed for assessment of cognitive functioning in older Mexican Americans. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 536-544. PMID 30364611 DOI: 10.1016/j.dadm.2018.08.003 |
0.633 |
|
| 2018 |
Hampel H, O'Bryant SE, Molinuevo JL, Zetterberg H, Masters CL, Lista S, Kiddle SJ, Batrla R, Blennow K. Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nature Reviews. Neurology. PMID 30297701 DOI: 10.1038/S41582-018-0079-7 |
0.344 |
|
| 2018 |
Martins RN, Villemagne V, Sohrabi HR, Chatterjee P, Shah TM, Verdile G, Fraser P, Taddei K, Gupta VB, Rainey-Smith SR, Hone E, Pedrini S, Lim WL, Martins I, Frost S, et al. Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies. Journal of Alzheimer's Disease : Jad. 62: 965-992. PMID 29562546 DOI: 10.3233/Jad-171145 |
0.314 |
|
| 2017 |
Gupta VB, Hone E, Pedrini S, Doecke J, O'Bryant S, James I, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Martins RN. Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 60-72. PMID 28508031 DOI: 10.1016/J.Dadm.2017.04.003 |
0.326 |
|
| 2017 |
Large S, Johnson LA, O'Jile J, O'Bryant S, Hall JR. [P3-305]: THE RELATIONSHIP BETWEEN SUBJECTIVE MEMORY COMPLAINTS AND AFFECTIVE SYMPTOMS IN MEXICAN AMERICANS WITH MILD COGNITIVE IMPAIRMENT Alzheimer's & Dementia. 13: P1063-P1063. DOI: 10.1016/J.Jalz.2017.06.1520 |
0.352 |
|
| 2017 |
Hall JR, Wiechmann AR, Johnson LA, Edwards M, O'Bryant S. [P3-234]: THE RELATIONSHIP OF METABOLIC AND INFLAMMATORY BIOMARKERS TO SUBJECTIVE COGNITIVE COMPLAINTS IN A SAMPLE OF COGNITIVELY NORMAL MEXICAN-AMERICANS Alzheimer's & Dementia. 13: P1028-P1028. DOI: 10.1016/J.Jalz.2017.06.1447 |
0.346 |
|
| 2016 |
O'Bryant SE, Mielke MM, Rissman RA, Lista S, Vanderstichele H, Zetterberg H, Lewczuk P, Posner H, Hall J, Johnson L, Fong YL, Luthman J, Jeromin A, Batrla-Utermann R, Villarreal A, et al. Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27870940 DOI: 10.1016/J.Jalz.2016.09.014 |
0.303 |
|
| 2016 |
Johnson LA, Gamboa A, Vintimilla R, Edwards M, Hall J, Weiser B, Yadav M, Dickensheets T, O'Bryant SE. A Depressive Endophenotype for Predicting Cognitive Decline among Mexican American Adults and Elders. Journal of Alzheimer's Disease : Jad. PMID 27472872 DOI: 10.1016/J.Jalz.2015.06.992 |
0.364 |
|
| 2016 |
O'Bryant SE, Edwards M, Johnson L, Hall J, Villarreal AE, Britton GB, Quiceno M, Cullum CM, Graff-Radford NR. A blood screening test for Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 3: 83-90. PMID 27453929 DOI: 10.1016/J.Dadm.2016.06.004 |
0.317 |
|
| 2016 |
Villarreal AE, O'Bryant SE, Edwards M, Grajales S, Britton GB. Serum-based protein profiles of Alzheimer's disease and mild cognitive impairment in elderly Hispanics. Neurodegenerative Disease Management. PMID 27229914 DOI: 10.2217/Nmt-2015-0009 |
0.373 |
|
| 2016 |
Richardson JR, Graber J, Harris G, German DC, O'Bryant S, Shalat S. P3-190: Relationship between Serum Pesticide Levels and Cognitive Function in Elderly Individuals in the United States: Race/Ethnicity Differences Alzheimer's & Dementia. 12: P894-P894. DOI: 10.1016/J.Jalz.2016.06.2396 |
0.334 |
|
| 2016 |
Hall JR, Wiechmann AR, Johnson LA, Edwards M, Gamboa A, O'Bryant S. P3-326: The Relationship of Subjective Cognitive Concerns and Cognitive Functioning in a Sample of Cognitively Normal Mexican-American Adults Alzheimer's & Dementia. 12: P971-P971. DOI: 10.1016/J.Jalz.2016.06.1982 |
0.361 |
|
| 2016 |
Edwards M, Hall JR, Johnson LA, O'Bryant S. P3-149: Diagnosis of Diabetes Mellitus Does Not Differentially Impact the Proteomic Profile of Mild Cognitive Impairment Among Mexican Americans Alzheimer's & Dementia. 12: P876-P876. DOI: 10.1016/J.Jalz.2016.06.1809 |
0.302 |
|
| 2015 |
Edwards M, Hall J, Williams B, Johnson L, O'Bryant S. Molecular Markers of Amnestic Mild Cognitive Impairment among Mexican Americans. Journal of Alzheimer's Disease : Jad. 49: 221-8. PMID 26444793 DOI: 10.3233/Jad-150553 |
0.355 |
|
| 2015 |
Torrence ND, John SE, Gavett BE, O'Bryant SE. An Empirical Comparison of Competing Factor Structures for the Repeatable Battery for the Assessment of Neuropsychological Status: A Project FRONTIER Study. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. PMID 26429558 DOI: 10.1093/arclin/acv057 |
0.584 |
|
| 2015 |
Lista S, Molinuevo JL, Cavedo E, Rami L, Amouyel P, Teipel SJ, Garaci F, Toschi N, Habert MO, Blennow K, Zetterberg H, O'Bryant SE, Johnson L, Galluzzi S, Bokde AL, et al. Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline. Journal of Alzheimer's Disease : Jad. PMID 26402088 DOI: 10.3233/Jad-150202 |
0.382 |
|
| 2015 |
Lista S, O'Bryant SE, Blennow K, Dubois B, Hugon J, Zetterberg H, Hampel H. Biomarkers in Sporadic and Familial Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 47: 291-317. PMID 26401553 DOI: 10.3233/Jad-143006 |
0.312 |
|
| 2015 |
Jahn DR, Dressel JA, Gavett BE, O'Bryant SE. An item response theory analysis of the Executive Interview and development of the EXIT8: A Project FRONTIER Study. Journal of Clinical and Experimental Neuropsychology. 37: 229-42. PMID 25748691 DOI: 10.1080/13803395.2014.1002757 |
0.598 |
|
| 2015 |
Laske C, Sohrabi HR, Frost SM, López-de-Ipiña K, Garrard P, Buscema M, Dauwels J, Soekadar SR, Mueller S, Linnemann C, Bridenbaugh SA, Kanagasingam Y, Martins RN, O'Bryant SE. Innovative diagnostic tools for early detection of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 561-78. PMID 25443858 DOI: 10.1016/J.Jalz.2014.06.004 |
0.353 |
|
| 2015 |
Johnson LA, Sohrabi HR, Hall JR, Kevin T, Edwards M, O'Bryant SE, Martins RN. A depressive endophenotype of poorer cognition among cognitively healthy community-dwelling adults: results from the Western Australia memory study. International Journal of Geriatric Psychiatry. 30: 881-6. PMID 25394326 DOI: 10.1002/Gps.4231 |
0.373 |
|
| 2015 |
O'Bryant SE, Gupta V, Henriksen K, Edwards M, Jeromin A, Lista S, Bazenet C, Soares H, Lovestone S, Hampel H, Montine T, Blennow K, Foroud T, Carrillo M, Graff-Radford N, et al. Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 549-60. PMID 25282381 DOI: 10.1016/J.Jalz.2014.08.099 |
0.333 |
|
| 2015 |
Edwards M, Johnson LA, Hall J, O'Bryant S. P3-069: Molecular markers of amnestic and nonamnestic mild cognitive impairment among mexican americans: A molecular neuropsychology approach Alzheimer's & Dementia. 11: P643-P643. DOI: 10.1016/J.Jalz.2015.06.936 |
0.323 |
|
| 2015 |
Hall J, Wiechmann AR, Edwards M, Johnson LA, O'Bryant S. P3-065: Association of biomarkers of vascular risk and inflammation to cognitive performance in mexican-american women: A hable study Alzheimer's & Dementia. 11: P642-P642. DOI: 10.1016/J.Jalz.2015.06.932 |
0.329 |
|
| 2014 |
O'Bryant SE, Xiao G, Zhang F, Edwards M, German DC, Yin X, Como T, Reisch J, Huebinger RM, Graff-Radford N, Dickson D, Barber R, Hall J, O'Suilleabhain P, Grammas P. Validation of a serum screen for Alzheimer's disease across assay platforms, species, and tissues. Journal of Alzheimer's Disease : Jad. 42: 1325-35. PMID 25024345 DOI: 10.3233/Jad-141041 |
0.305 |
|
| 2014 |
Edwards M, Balldin VH, Hall J, O'Bryant S. Combining select neuropsychological assessment with blood-based biomarkers to detect mild Alzheimer's disease: a molecular neuropsychology approach. Journal of Alzheimer's Disease : Jad. 42: 635-40. PMID 24916542 DOI: 10.3233/Jad-140852 |
0.367 |
|
| 2014 |
Cunningham RL, Singh M, O'Bryant SE, Hall JR, Barber RC. Oxidative stress, testosterone, and cognition among Caucasian and Mexican-American men with and without Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 40: 563-73. PMID 24496073 DOI: 10.3233/Jad-131994 |
0.308 |
|
| 2014 |
Snyder HM, Carrillo MC, Grodstein F, Henriksen K, Jeromin A, Lovestone S, Mielke MM, O'Bryant S, Sarasa M, Sjøgren M, Soares H, Teeling J, Trushina E, Ward M, West T, et al. Developing novel blood-based biomarkers for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 109-14. PMID 24365657 DOI: 10.1016/J.Jalz.2013.10.007 |
0.312 |
|
| 2014 |
Johnson LA, Cushing B, Rohlfing G, Edwards M, Davenloo H, D'Agostino D, Hall JR, O'Bryant SE. The Hachinski ischemic scale and cognition: the influence of ethnicity. Age and Ageing. 43: 364-9. PMID 24321843 DOI: 10.1093/Ageing/Aft189 |
0.381 |
|
| 2014 |
Falkowski J, Atchison T, Debutte-Smith M, Weiner MF, O'Bryant S. Executive functioning and the metabolic syndrome: a project FRONTIER study. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 29: 47-53. PMID 24152591 DOI: 10.1093/Arclin/Act078 |
0.312 |
|
| 2014 |
O'Bryant SE, Xiao G, Barber R, Cullum CM, Weiner M, Hall J, Edwards M, Grammas P, Wilhelmsen K, Doody R, Diaz-Arrastia R. Molecular neuropsychology: creation of test-specific blood biomarker algorithms. Dementia and Geriatric Cognitive Disorders. 37: 45-57. PMID 24107792 DOI: 10.1159/000345605 |
0.339 |
|
| 2014 |
Hall JR, Edwards M, Barber RC, O'Bryant S. P3-081: GLP-1 AND DELAYED MEMORY PERFORMANCE AMONG MILD COGNITIVE IMPAIRMENT CASES WITH AND WITHOUT DIABETES MELLITUS Alzheimer's & Dementia. 10: P656-P657. DOI: 10.1016/J.Jalz.2014.05.1169 |
0.311 |
|
| 2013 |
Jahn DR, Mauer CB, Menon CV, Edwards ML, Dressel JA, O'Bryant SE. A brief Spanish-English equivalent version of the Boston Naming Test: a Project FRONTIER study. Journal of Clinical and Experimental Neuropsychology. 35: 835-45. PMID 23998641 DOI: 10.1080/13803395.2013.825234 |
0.763 |
|
| 2013 |
Menon C, Westervelt HJ, Jahn DR, Dressel JA, O'Bryant SE. Normative performance on the Brief Smell Identification Test (BSIT) in a multi-ethnic bilingual cohort: a Project FRONTIER study. The Clinical Neuropsychologist. 27: 946-61. PMID 23634698 DOI: 10.1080/13854046.2013.796406 |
0.783 |
|
| 2013 |
O'Bryant SE, Johnson L, Edwards M, Soares H, Devous MD, Ross S, Rohlfing G, Hall J. The link between C-reactive protein and Alzheimer's disease among Mexican Americans. Journal of Alzheimer's Disease : Jad. 34: 701-6. PMID 23254637 DOI: 10.3233/Jad-122071 |
0.331 |
|
| 2013 |
Menon CV, Jahn DR, Mauer CB, O'Bryant SE. Executive functioning as a mediator of the relationship between premorbid verbal intelligence and health risk behaviors in a rural-dwelling cohort: a Project FRONTIER study. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 28: 169-79. PMID 23192834 DOI: 10.1093/Arclin/Acs102 |
0.757 |
|
| 2013 |
Johnson LA, Mauer C, Jahn D, Song M, Wyshywaniuk L, Hall JR, Balldin VH, O'Bryant SE. Cognitive differences among depressed and non-depressed MCI participants: a project FRONTIER study. International Journal of Geriatric Psychiatry. 28: 377-82. PMID 22653735 DOI: 10.1002/Gps.3835 |
0.33 |
|
| 2013 |
Devous M, Fatt CC, Abdi H, Harris T, Hynanc L, O'Bryant S. O4-03-04: Delineating the relationship between cognitive measures and functional connectivity in Alzheimer's disease Alzheimer's & Dementia. 9: P685-P685. DOI: 10.1016/J.Jalz.2013.04.349 |
0.348 |
|
| 2012 |
Balldin VH, Hall JR, Barber RC, Hynan L, Diaz-Arrastia R, O'Bryant SE. The Relation between Inflammation and Neuropsychological Test Performance. International Journal of Alzheimer's Disease. 2012: 703871. PMID 23008797 DOI: 10.1155/2012/703871 |
0.324 |
|
| 2012 |
Spering CC, Hobson V, Lucas JA, Menon CV, Hall JR, O'Bryant SE. Diagnostic accuracy of the MMSE in detecting probable and possible Alzheimer's disease in ethnically diverse highly educated individuals: an analysis of the NACC database. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 67: 890-6. PMID 22396476 DOI: 10.1093/gerona/gls006 |
0.758 |
|
| 2012 |
Pedraza O, Clark JH, O'Bryant SE, Smith GE, Ivnik RJ, Graff-Radford NR, Willis FB, Petersen RC, Lucas JA. Diagnostic validity of age and education corrections for the Mini-Mental State Examination in older African Americans. Journal of the American Geriatrics Society. 60: 328-31. PMID 22150301 DOI: 10.1111/J.1532-5415.2011.03766.X |
0.343 |
|
| 2012 |
Menon C, Hall J, Hobson V, Johnson L, O'Bryant SE. Normative performance on the executive clock drawing task in a multi-ethnic bilingual cohort: a project FRONTIER study. International Journal of Geriatric Psychiatry. 27: 959-66. PMID 22052628 DOI: 10.1002/Gps.2810 |
0.769 |
|
| 2012 |
Edwards M, Hall J, O'Bryant S. P2-165: Higher vanadium levels differentially impacted neuropsychological functioning in cases of normal cognition and mild cognitive impairment: A project FRONTIER study Alzheimer's & Dementia. 8: P316-P316. DOI: 10.1016/J.Jalz.2012.05.871 |
0.354 |
|
| 2012 |
Edwards M, Hall J, O'Bryant S. P1-120: Higher groundwater vanadium levels are associated with better cognitive functioning in a sample of cases with diabetes mellitus: A Project FRONTIER study Alzheimer's & Dementia. 8: P148-P148. DOI: 10.1016/J.Jalz.2012.05.397 |
0.327 |
|
| 2011 |
Hall JR, O'Bryant SE, Johnson LA, Barber RC. Depressive symptom clusters and neuropsychological performance in mild Alzheimer's and cognitively normal elderly. Depression Research and Treatment. 2011: 396958. PMID 21904674 DOI: 10.1155/2011/396958 |
0.403 |
|
| 2011 |
O'Bryant SE, Xiao G, Barber R, Reisch J, Hall J, Cullum CM, Doody R, Fairchild T, Adams P, Wilhelmsen K, Diaz-Arrastia R. A blood-based algorithm for the detection of Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 32: 55-62. PMID 21865746 DOI: 10.1159/000330750 |
0.313 |
|
| 2011 |
Johnson LA, Hobson V, Jenkins M, Dentino A, Ragain RM, O'Bryant S. The influence of thyroid function on cognition in a sample of ethnically diverse, rural-dwelling women: a project FRONTIER study. The Journal of Neuropsychiatry and Clinical Neurosciences. 23: 219-22. PMID 21677255 DOI: 10.1176/Jnp.23.2.Jnp219 |
0.37 |
|
| 2011 |
O'Bryant SE, Edwards M, Menon CV, Gong G, Barber R. Long-term low-level arsenic exposure is associated with poorer neuropsychological functioning: a Project FRONTIER study. International Journal of Environmental Research and Public Health. 8: 861-74. PMID 21556183 DOI: 10.3390/ijerph8030861 |
0.763 |
|
| 2011 |
Duff K, Spering CC, O'Bryant SE, Beglinger LJ, Moser DJ, Bayless JD, Culp KR, Mold JW, Adams RL, Scott JG. The RBANS Effort Index: base rates in geriatric samples. Applied Neuropsychology. 18: 11-7. PMID 21390895 DOI: 10.1080/09084282.2010.523354 |
0.563 |
|
| 2011 |
O'Bryant SE, Hobson VL, Hall JR, Barber RC, Zhang S, Johnson L, Diaz-Arrastia R. Serum brain-derived neurotrophic factor levels are specifically associated with memory performance among Alzheimer's disease cases. Dementia and Geriatric Cognitive Disorders. 31: 31-6. PMID 21135555 DOI: 10.1159/000321980 |
0.308 |
|
| 2011 |
Wiechmann A, Hall JR, O'Bryant SE. The utility of the spatial span in a clinical geriatric population. Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition. 18: 56-63. PMID 20924826 DOI: 10.1080/13825585.2010.510556 |
0.378 |
|
| 2011 |
Hobson VL, Hall JR, Harvey M, Cullum CM, Lacritz L, Massman PJ, Waring SC, O'Bryant SE. An examination of the Boston Naming Test: calculation of "estimated" 60-item score from 30- and 15-item scores in a cognitively impaired population. International Journal of Geriatric Psychiatry. 26: 351-5. PMID 20690129 DOI: 10.1002/Gps.2533 |
0.37 |
|
| 2011 |
O'Bryant SE, Hall JR, Cukrowicz KC, Edwards M, Johnson LA, Lefforge D, Jenkins M, Dentino A. The differential impact of depressive symptom clusters on cognition in a rural multi-ethnic cohort: a Project FRONTIER study. International Journal of Geriatric Psychiatry. 26: 199-205. PMID 20661882 DOI: 10.1002/Gps.2514 |
0.398 |
|
| 2011 |
Hall JR, O'Bryant SE, Johnson L, Barber RC. Depression and Brain-derived Neurotrophic Factor Levels in Alzheimer's Disease Neuroscience and Medicine. 2: 43-47. DOI: 10.4236/Nm.2011.21006 |
0.305 |
|
| 2011 |
Royall DR, Doody R, Barber R, Palmer R, O'Bryant S, Reisch J, Fairchild T, Adams P. The Cognitive Correlates of Functional Status: A New Approach to Dementia Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.484 |
0.34 |
|
| 2010 |
Duff K, Hobson VL, Beglinger LJ, O'Bryant SE. Diagnostic accuracy of the RBANS in mild cognitive impairment: limitations on assessing milder impairments. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 25: 429-41. PMID 20570820 DOI: 10.1093/Arclin/Acq045 |
0.609 |
|
| 2010 |
O'Bryant SE, Waring SC, Hobson V, Hall JR, Moore CB, Bottiglieri T, Massman P, Diaz-Arrastia R. Decreased C-reactive protein levels in Alzheimer disease. Journal of Geriatric Psychiatry and Neurology. 23: 49-53. PMID 19933496 DOI: 10.1177/0891988709351832 |
0.322 |
|
| 2009 |
Duff K, O'Bryant SE, Westervelt HJ, Sweet JJ, Reynolds CR, van Gorp WG, Tranel D, McCaffrey RJ. On becoming a peer reviewer for a neuropsychology journal. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 24: 201-7. PMID 19640873 DOI: 10.1093/Arclin/Acp031 |
0.636 |
|
| 2009 |
O'Bryant SE, Hobson V, Hall JR, Waring SC, Chan W, Massman P, Lacritz L, Cullum CM, Diaz-Arrastia R. Brain-derived neurotrophic factor levels in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 17: 337-41. PMID 19363274 DOI: 10.3233/Jad-2009-1051 |
0.348 |
|
| 2008 |
Duff K, Humphreys Clark JD, O'Bryant SE, Mold JW, Schiffer RB, Sutker PB. Utility of the RBANS in detecting cognitive impairment associated with Alzheimer's disease: sensitivity, specificity, and positive and negative predictive powers. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 23: 603-12. PMID 18639437 DOI: 10.1016/J.Acn.2008.06.004 |
0.618 |
|
| 2008 |
O'Bryant SE, Humphreys JD, Smith GE, Ivnik RJ, Graff-Radford NR, Petersen RC, Lucas JA. Detecting dementia with the mini-mental state examination in highly educated individuals. Archives of Neurology. 65: 963-7. PMID 18625866 DOI: 10.1001/Archneur.65.7.963 |
0.336 |
|
| 2008 |
O'Bryant SE, Gavett BE, McCaffrey RJ, O'Jile JR, Huerkamp JK, Smitherman TA, Humphreys JD. Clinical utility of Trial 1 of the Test of Memory Malingering (TOMM). Applied Neuropsychology. 15: 113-6. PMID 18568603 DOI: 10.1080/09084280802083921 |
0.703 |
|
| 2008 |
O'Bryant S. Exploring the relation between culture and cognition Journal of Clinical and Experimental Neuropsychology. 30: 967-970. DOI: 10.1080/13803390801937175 |
0.307 |
|
| 2007 |
O'Bryant SE, Humphreys JD, Bauer L, McCaffrey RJ, Hilsabeck RC. The influence of ethnicity on Symbol Digit Modalities Test performance: an analysis of a multi-ethnic college and hepatitis C patient sample. Applied Neuropsychology. 14: 183-8. PMID 17848129 DOI: 10.1080/09084280701508986 |
0.558 |
|
| 2007 |
Bauer L, O'Bryant SE, Lynch JK, McCaffrey RJ, Fisher JM. Examining the Test Of Memory Malingering Trial 1 and Word Memory Test Immediate Recognition as screening tools for insufficient effort. Assessment. 14: 215-22. PMID 17690378 DOI: 10.1177/1073191106297617 |
0.567 |
|
| 2007 |
O'Bryant SE, Engel LR, Kleiner JS, Vasterling JJ, Black FW. Test of memory malingering (TOMM) trial 1 as a screening measure for insufficient effort. The Clinical Neuropsychologist. 21: 511-21. PMID 17455034 DOI: 10.1080/13854040600611368 |
0.36 |
|
| 2007 |
O'Bryant SE, Lucas JA, Willis FB, Smith GE, Graff-Radford NR, Ivnik RJ. Discrepancies between self-reported years of education and estimated reading level among elderly community-dwelling African-Americans: Analysis of the MOAANS data. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 22: 327-32. PMID 17336494 DOI: 10.1016/J.Acn.2007.01.007 |
0.309 |
|
| 2006 |
O'Bryant SE, McCaffrey RJ. Preliminary findings on the Cross Cultural Test Of Face Recognition. Applied Neuropsychology. 13: 223-9. PMID 17362142 DOI: 10.1207/S15324826An1304_3 |
0.597 |
|
| 2006 |
O'Bryant SE, Lucas JA. Estimating the predictive value of the Test of Memory Malingering: an illustrative example for clinicians. The Clinical Neuropsychologist. 20: 533-40. PMID 16895864 DOI: 10.1080/13854040590967568 |
0.336 |
|
| 2006 |
Large S, O'Jile J, Hall JR, O'Bryant S, Johnson LA. P3-498: CHARACTERIZATION OF WORRY AND COGNITION IN MEXICAN AMERICAN WOMEN Alzheimer's & Dementia. 14: P1313-P1313. DOI: 10.1016/J.Jalz.2018.06.1862 |
0.307 |
|
| 2006 |
Hall JR, Johnson LA, Wiechmann AR, Edwards M, O'Bryant S. P3-324: CHARACTERISTICS OF COGNITIVELY NORMAL OLDER MEXICAN AMERICANS AND NON-HISPANIC WHITES WITH SUBJECTIVE COGNITIVE COMPLAINTS Alzheimer's & Dementia. 14: P1205-P1205. DOI: 10.1016/J.Jalz.2018.06.1685 |
0.347 |
|
| 2006 |
O'Jile J, Large S, O'Bryant S, Hall JR, Johnson LA. P2-554: CHARACTERIZATION OF WORRY AND ITS EFFECT ON COGNITION IN MEXICAN AMERICAN WOMEN Alzheimer's & Dementia. 14: P949-P949. DOI: 10.1016/J.Jalz.2018.06.1249 |
0.309 |
|
| 2005 |
O'Bryant SE, Marcus DA, Rains JC, Penzien DB. Neuropsychology of migraine: present status and future directions. Expert Review of Neurotherapeutics. 5: 363-70. PMID 15938669 DOI: 10.1586/14737175.5.3.363 |
0.357 |
|
| 2005 |
Gavett BE, O'Bryant SE, Fisher JM, McCaffrey RJ. Hit rates of adequate performance based on the test of memory malingering (TOMM) Trial 1. Applied Neuropsychology. 12: 1-4. PMID 15788216 DOI: 10.1207/S15324826An1201_1 |
0.707 |
|
| 2004 |
O'Bryant SE, O'Jile JR, McCaffrey RJ. Reporting of demographic variables in neuropsychological research: trends in the current literature. The Clinical Neuropsychologist. 18: 229-33. PMID 15587670 DOI: 10.1080/13854040490501439 |
0.521 |
|
| 2004 |
O'Bryant SE, Duff K, Fisher J, McCaffrey RJ. Performance profiles and cut-off scores on the Memory Assessment Scales. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 19: 489-96. PMID 15163450 DOI: 10.1016/J.Acn.2003.07.001 |
0.671 |
|
| 2003 |
O'Bryant SE, Hilsabeck RC, McCaffrey RJ, Drew Gouvier W. The Recognition Memory Test Examination of ethnic differences and norm validity. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 18: 135-43. PMID 14591465 DOI: 10.1016/S0887-6177(01)00189-5 |
0.552 |
|
| 2003 |
O'Bryant SE, Palav A, McCaffrey RJ. A review of symptoms commonly associated with menopause: implications for clinical neuropsychologists and other health care providers. Neuropsychology Review. 13: 145-52. PMID 14584909 DOI: 10.1023/A:1025573529407 |
0.731 |
|
| 2003 |
Ashendorf L, O'Bryant SE, McCaffrey RJ. Specificity of malingering detection strategies in older adults using the CVLT and WCST. The Clinical Neuropsychologist. 17: 255-62. PMID 13680433 DOI: 10.1076/Clin.17.2.255.16502 |
0.751 |
|
| 2003 |
O'Bryant SE, Hilsabeck RC, Fisher JM, McCaffrey RJ. Utility of the trail making test in the assessment of malingering in a sample of mild traumatic brain injury litigants. The Clinical Neuropsychologist. 17: 69-74. PMID 12854012 DOI: 10.1076/Clin.17.1.69.15624 |
0.547 |
|
| 2003 |
McCaffrey RJ, O'Bryant SE, Ashendorf L, Fisher JM. Correlations among the TOMM, Rey-15, and MMPI-2 validity scales in a sample of TBI litigants Journal of Forensic Neuropsychology. 3: 45-53. DOI: 10.1300/J151v03n03_03 |
0.731 |
|
| Show low-probability matches. |